As of 2025-07-17, the Fair Value of Emmaus Life Sciences Inc (EMMA) is -0.35 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.01 USD, the upside of Emmaus Life Sciences Inc is -2,557.98%.
With the market price of 0.01 USD and our fair value calculation, Emmaus Life Sciences Inc (EMMA) is not a good investment. Investing in EMMA stocks now will result in a potential loss of 2,557.98%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 1.35 | -15.95 | -10.63 | -3.73 | -6.45 | -7.08 |
| YoY growth | 102.46% | -1,281.48% | 33.35% | 64.88% | -72.86% | -230.73% |
| Market Cap (mil) | 0.90 |
| P/E | |
| Forward P/E |
| EPS | -0.07 |
| Avg earnings growth rate | -230.73% |
| TTM earnings | -4.43 |